A novel non-viral gene transfer system, polycation liposomes

被引:59
|
作者
Oku, N [1 ]
Yamazaki, Y
Matsuura, M
Sugiyama, M
Hasegawa, M
Nango, M
机构
[1] Univ Shizuoka, Dept Med Biochem, Sch Pharmaceut Sci, Shizuoka 4228526, Japan
[2] DNAVEC Res Inc, Tsukuba, Ibaraki, Japan
[3] Nagoya Inst Technol, Dept Appl Chem, Nagoya, Aichi 466, Japan
关键词
gene transfer; liposome; polycation; cationic liposome; polyethylenimine; gene therapy;
D O I
10.1016/S0169-409X(01)00212-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To develop a novel non-viral gene transfer system, liposome was modified with cetylated polyethylenimine (PEI). This polycation liposome (PCL) showed remarkable transfection efficiency to COS-1 cells in vitro, in comparison with conventional cationic liposome preparations. Cytotoxicity against COS-1 cells and hemolytic activity of PCL or PCL-DNA complex were quite low in comparison with conventional cationic liposomes. Most conventional cationic liposomes require phosphatidylethanolamine or cholesterol as a component, though PCL did not. Egg yolk phosphatidylcholine- and dipalmitoylphosphatidylcholine-based PCL were as effective as dioleoylphosphatidylethanolamine-based PCL for gene transfer. Furthermore, the transfection efficacy of PCL was enhanced, instead of being diminished, in the presence of serum. Effective gene transfer was observed in all eight malignant and two normal line cells tested as well as in COS-1 cells. The effect of the molecular weight of PEI on PCL-mediated gene transfer was examined, and observed that PEIs with a molecular weight (Mr. Wt.) of 600 and 1800 Da were quite effective but PEI of 25 000 was far less effective. Effectiveness of gene transfer by using PCL was also observed in vivo: GFP and Luciferase genes were effectively expressed in mouse. We also discussed the mechanism of gene transfer by PCL. Taken together, PCL represents a new system useful for transfection and gene therapy. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:209 / 218
页数:10
相关论文
共 50 条
  • [41] In vivo gene transfer by targeted non-viral gene delivery.
    Sullivan, SM
    Anwer, K
    Szymanski, P
    Kao, G
    Shelvin, B
    Xiang, Q
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U559 - U559
  • [42] Non-viral gene transfer: Applications in developmental biology and gene therapy
    Abdallah, B
    Sachs, L
    Demeneix, BA
    BIOLOGY OF THE CELL, 1995, 85 (01) : 1 - 7
  • [43] Muscle gene transfer mediated by mesoangioblasts and non-viral vectors
    Iyer, Pavithra S.
    van Zwieten, Ruthger
    Ley, Deborah
    Mermod, Nicolas
    HUMAN GENE THERAPY, 2014, 25 (11) : A73 - A73
  • [44] Non-Viral Ocular Gene Transfer for Hereditary Retinal Degeneration
    Naash, Muna I.
    Ballard, Ron M.
    Skaggs, Jeff
    Nash, Zack
    Quiambao, Alexander B.
    Cooper, Mark J.
    Farjo, Rafal
    MOLECULAR THERAPY, 2006, 13 : S340 - S340
  • [45] Chemical enhancers of non-viral salivary gland gene transfer
    McMahon, BM
    Chen, YJ
    Niedzinski, EJ
    Bennett, MJ
    MOLECULAR THERAPY, 2004, 9 : S57 - S57
  • [46] Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer
    Wagstaff, Kylie M.
    Jans, David A.
    BIOCHEMICAL JOURNAL, 2007, 406 (02) : 185 - 202
  • [47] Non-viral methods for gene transfer towards osteosarcoma therapy
    Dass, Crispin R.
    Choong, Peter F. M.
    JOURNAL OF DRUG TARGETING, 2007, 15 (03) : 184 - 189
  • [48] Peptide-mediated non-viral gene transfer for transplantation
    George, AJT
    TRANSPLANTATION, 2000, 69 (06) : 1031 - 1033
  • [49] Non-viral gene transfer using integrating vector systems
    Izsvak, Suzanna
    HUMAN GENE THERAPY, 2009, 20 (11) : 1356 - 1357
  • [50] New non-viral method for gene transfer into primary cells
    Gresch, O
    Engel, FB
    Nesic, D
    Tran, TT
    England, HM
    Hickman, ES
    Körner, I
    Gan, L
    Chen, S
    Castro-Obregon, S
    Hammermann, R
    Wolf, J
    Müller-Hartmann, H
    Nix, M
    Siebenkotten, G
    Kraus, G
    Lun, K
    METHODS, 2004, 33 (02) : 151 - 163